Analysis of risk factors and different treatments for infections caused by carbapenem-resistant Acinetobacter baumannii in Shaanxi, China

被引:0
作者
He, Xiaoliang [1 ]
Tang, Jin [1 ]
He, Sanjun [1 ]
Huang, Xiaoxia [1 ]
机构
[1] Hanzhong Cent Hosp, Dept Clin Lab, 22 Kangfu Rd, Hanzhong, Shaanxi, Peoples R China
关键词
Molecular epidemiology; Drug resistance; Mortality; Prognosis; KLEBSIELLA-PNEUMONIAE; CLINICAL ISOLATE; MORTALITY; PREDICTORS; SULBACTAM; EVOLUTION; OUTCOMES;
D O I
10.1186/s12879-024-10036-5
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background The global threat of Carbapenem-resistant Acinetobacter baumannii (CRAB) has intensified as resistance to carbapenems continues to rise in recent decades. We aimed to explore risk factors, molecular epidemiology, and antimicrobial therapy of CRAB infection. Methods The clinical data of 110 patients infected with A. baumannii from December 2021 to December 2022 were retrospectively analyzed. Patients were divided into a carbapenem-resistance group (55 patients) and carbapenem-sensitive group (CSAB; 55 patients) based on resistance to carbapenem, and the risk factors of patients infected with CRAB were analyzed. Fifty-five patients with CRAB infection who received antimicrobial therapy were divided into a combination therapy group (45 patients) and a monotherapy group (10 patients), and differences between the two groups were compared. Whole-genome sequencing analysis was performed to assess resistance genes. Phylogenetic analysis was performed to explore the characteristics of CRAB isolates. Results Among the total 110 patients, the rate of poor prognosis in the CRAB group was 43.6% (24/55). Mechanical ventilation (odds ratio [OR] = 5.364, 95% confidence interval [CI] 1.462-19.679, P = 0.011) and puncture (OR = 19.935, 95% CI 1.261-315.031, P = 0.012) were independent risk factors for CRAB infection. Of 55 patients in the antimicrobial regimen study, 45 received combination therapy (including dual, triple, or quadruple antibiotic therapy) and 10 received monotherapy. Univariate analysis revealed significant differences between the combination group and monotherapy group for admission to the intensive care unit and wound infection (P < 0.05). The CRAB strains of 26 patients taking carbapenem-based combination therapy were mainly ST208, ST1968, and ST195, among which patients with ST1968 strains had higher 28-day mortality. Furthermore, the blaOXA-23 gene was harbored in ST1968, ST195, and ST208. Conclusions Mortality was significantly higher in patients infected with CRAB than with CSAB. Mechanical ventilation and puncture were independent risk factors in predicting CRAB infections. The distribution of CRAB was dominated by ST208, ST1968, and ST195, among which patients with ST1968 had higher 28-day mortality. The blaOXA-23 gene appears to be widely disseminated.
引用
收藏
页数:9
相关论文
共 50 条
[31]   Molecular Epidemiology and Risk Factors of Carbapenem-Resistant Klebsiella pneumoniae Infections in Eastern China [J].
Zheng, Bing ;
Dai, Yingxin ;
Liu, Yang ;
Shi, Weiyang ;
Dai, Erkuan ;
Han, Yichao ;
Zheng, Dandan ;
Yu, Yuetian ;
Li, Min .
FRONTIERS IN MICROBIOLOGY, 2017, 8
[32]   Comparison between bacteremia caused by carbapenem resistant Acinetobacter baumannii and Acinetobacter nosocomialis [J].
Yang, Ya-Sung ;
Lee, Yi-Tzu ;
Tsai, Wen-Chiuan ;
Kuo, Shu-Chen ;
Sun, Jun-Ren ;
Yang, Chin-Hsuan ;
Chen, Te-Li ;
Lin, Jung-Chung ;
Fung, Chang-Phone ;
Chang, Feng-Yee .
BMC INFECTIOUS DISEASES, 2013, 13
[33]   Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients:: risk factors for acquisition, infection and their consequences [J].
Playford, E. G. ;
Craig, J. C. ;
Iredell, J. R. .
JOURNAL OF HOSPITAL INFECTION, 2007, 65 (03) :204-211
[34]   Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenem-resistant Acinetobacter baumannii [J].
Liang, C. -A. ;
Lin, Y. -C. ;
Lu, P. -L. ;
Chen, H. -C. ;
Chang, H. -L. ;
Sheu, C. -C. .
CLINICAL MICROBIOLOGY AND INFECTION, 2018, 24 (08) :908.e1-908.e7
[35]   Carbapenem-resistant Acinetobacter baumannii causing osteomyelitis and infections of skin and soft tissues in hospitals of Medellin, Colombia [J].
Marcela Vanegas, Johanna ;
Felipe Higuita, Luis ;
Andres Vargas, Carlos ;
Vanessa Cienfuegos, Astrid ;
Andrea Rodriguez, Erika ;
Eduardo Roncancio, Gustavo ;
Natalia Jimenez, Judy .
BIOMEDICA, 2015, 35 (04) :522-530
[36]   Risk Factors for Occurrence and 30-Day Mortality for Carbapenem-Resistant Acinetobacter baumannii Bacteremia in an Intensive Care Unit [J].
Kim, Song Yee ;
Jung, Ji Ye ;
Kang, Young Ae ;
Lim, Joo Eun ;
Kim, Eun Young ;
Lee, Sang Kook ;
Park, Seon Cheol ;
Chung, Kyung Soo ;
Park, Byung Hoon ;
Kim, Young Sam ;
Kim, Se Kyu ;
Chang, Joon ;
Park, Moo Suk .
JOURNAL OF KOREAN MEDICAL SCIENCE, 2012, 27 (08) :939-947
[37]   Multisite Infections Caused by Carbapenem-Resistant Klebsiella Pneumoniae: Unveiling the Clinical Characteristics and Risk Factors [J].
Li, Jing ;
Wu, Shunjun ;
Zhang, Huanhuan ;
Guo, Xingxing ;
Meng, Wanting ;
Zhao, Heng ;
Song, Liqiang .
ANTIBIOTICS-BASEL, 2025, 14 (07)
[38]   Risk factors and outcomes in patients with carbapenem-resistant Acinetobacter infection [J].
Vitkauskiene, Astra ;
Dambrauskiene, Asta ;
Cerniauskiene, Kristina ;
Rimdeika, Rytis ;
Sakalauskas, Raimundas .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2013, 45 (03) :213-218
[39]   Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes [J].
Routsi, C. ;
Pratikaki, M. ;
Platsouka, E. ;
Sotiropoulou, C. ;
Nanas, S. ;
Markaki, V. ;
Vrettou, C. ;
Paniara, O. ;
Giamarellou, H. ;
Roussos, C. .
INFECTION, 2010, 38 (03) :173-180
[40]   Socioeconomic Burden of Bloodstream Infections Caused by Carbapenem-Resistant Enterobacteriaceae [J].
Zhu, Yunying ;
Xiao, Tingting ;
Wang, Yuan ;
Yang, Kai ;
Zhou, Yanzi ;
Luo, Qixia ;
Shen, Ping ;
Xiao, Yonghong .
INFECTION AND DRUG RESISTANCE, 2021, 14 :5385-5393